osimelnitinib

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

July, 2025

osimelnitinib

Dec 23, 2023, 03:25 | Drugs

Katsuaki Maehara: Therapeutic development of 4th generation TKIs is active for acquired resistance to osimelnitinib for C797

Katsuaki Maehara, Director of Medical Education Colleagues, recently shared the following on X/Twitter: "Therapeutic development…

All: 1 Posts: 1 - 100

'

Garo Armen Shares a Personal Story Driving Agenus' Mission in Cancer Care

'

Dr. Oliver Bogler, PhD: Leaving the National Cancer Institute

'

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care

'

Sibylle Loibl: Final survival Results from the PENELOPE-B trial published in Annals of Oncology

'

Yvonne Awards 2025: Honoring Global Oncology Leaders at ASCO’s Most Inspiring Night

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023